GATTAZZO, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1681
EU - Europa 229
AS - Asia 175
OC - Oceania 1
SA - Sud America 1
Totale 2087
Nazione #
US - Stati Uniti d'America 1681
CN - Cina 148
IT - Italia 67
DE - Germania 50
FI - Finlandia 36
SE - Svezia 36
GB - Regno Unito 32
VN - Vietnam 19
IN - India 6
UA - Ucraina 4
FR - Francia 2
AU - Australia 1
CL - Cile 1
ES - Italia 1
JP - Giappone 1
KW - Kuwait 1
RU - Federazione Russa 1
Totale 2087
Città #
Fairfield 295
Woodbridge 259
Houston 197
Ann Arbor 148
Cambridge 123
Ashburn 116
Seattle 108
Wilmington 104
Chandler 94
Beijing 39
Padova 37
Princeton 32
Nanjing 30
Jacksonville 26
San Diego 25
Medford 22
Dong Ket 19
Des Moines 14
Falls Church 11
Helsinki 11
Jinan 9
Redwood City 9
Shenyang 9
Changsha 8
Hebei 5
Nanchang 5
Roxbury 5
Chicago 4
Hangzhou 4
Haikou 3
Indiana 3
Jiaxing 3
Norwalk 3
Phoenix 3
Auburn Hills 2
Baotou 2
Borås 2
Fuzhou 2
Hefei 2
Kunming 2
Marcon 2
Milan 2
Ningbo 2
Nürnberg 2
Piazzola Sul Brenta 2
Taiyuan 2
Taizhou 2
Tianjin 2
Wuhan 2
Zhengzhou 2
Alghero 1
Avenel 1
Bolzano 1
Guangzhou 1
Hanover 1
Kuwait City 1
Lafayette 1
Lanzhou 1
London 1
Los Angeles 1
Martellago 1
Melbourne 1
Paliano 1
Porto Torres 1
San Francisco 1
Sassari 1
Shanghai 1
Tettnang 1
Tokyo 1
Veneto 1
Venezia 1
Zhoushan 1
Totale 1837
Nome #
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction? 137
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model of Pulmonary Inflammation and Fibrosis 117
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 114
Sarcoidosis is a Th1/Th17 multisystem disorder 112
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 112
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 108
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 107
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 105
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 105
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 103
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 92
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 90
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 85
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 85
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 82
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 76
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 69
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 67
S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis. 63
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 61
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 49
Phosphorylation of PP2A by Lyn is a key phenomenon in the cancer phenotype of B-CLL 47
Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases? 38
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 33
Leukemic cell from B-CLL patients display heterogeneous response to the anti-apoptotic effect of mesenchymal stromal cells 28
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 27
Role of inflammation in the development of lung fibrosis and in the pathogenesis of pulmunary hypertension 10
Totale 2122
Categoria #
all - tutte 2833
article - articoli 2795
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201870 001120 41 512 01142
2018/2019242 15180 36 123 6338363
2019/2020551 6725228 5437 6465 62813927
2020/2021359 32271323 1821 1240 46504631
2021/2022407 12364161 1524 1750 1533499
2022/2023139 775660 00 00 0000
Totale 2122